Table 3.
Predictors of asymptomatic hyperuricemia. Univariate analysis.
| Subjects with Hyperuricemia (n = 232) OR (CI%95) |
p-Value | |
|---|---|---|
| Age (years) ≥ 65 | 1.77 (1.28–2.44) | <0.001 |
| Males (%) | 1.06 (0.79–1.43) | 0.669 |
| Non-smokers | 1.13 (0.83–1.54) | 0.434 |
| Current Smokers (%) | 0.65 (0.43–0.99) | 0.047 |
| Ex-smokers (%) | 1.12 (0.84–1.50) | 0.420 |
| Hypertension (%) | 2.82 (2.00–3.97) | <0.001 |
| Dyslipidemia (%) | 0.77 (0.51–1.14) | 0.201 |
| Diabetes (%) | 1.50 (1.10–2.04) | 0.009 |
| Sedentary (%) | 1.33 (0.98–1.79) | 0.062 |
| Metabolic Syndrome (%) | 2.18 (1.62–2.93) | <0.001 |
| CV event (%) | 1.54 (1.12–2.13) | 0.008 |
| SBP (mmHg) ≥ 140 | 1.43 (1.07–1.92) | 0.015 |
| DBP (mmHg) ≥ 90 | 0.90 (0.63–1.27) | 0.566 |
| PP (mmHg) ≥ 60 | 1.84 (1.39–2.49) | <0.001 |
| TC (mg/dL) ≥ 190 | 0.70 (0.50–0.96) | 0.031 |
| LDL (mg/dL) ≥ 100 | 0.70 (0.52–0.95) | 0.024 |
| Triglyceride (mg/dL) ≥ 200 | 1.57 (1.09–2.25) | 0.014 |
| FPG (mg/dL) ≥ 126 | 0.67 (0.47–0.95) | 0.028 |
| HbA1C (%) ≥ 6.5 | 1.31 (0.92–1.87) | 0.123 |
| Antihypertensive drugs (%) | 2.70 (1.95–3.75) | <0.001 |
| Lipid-lowering drugs (%) | 0.78 (0.56–1.09) | 0.149 |
| Antidiabetic drugs (%) | 1.52 (1.11–2.08) | 0.008 |
Abbreviations: CV, cardiovascular; DBP, diastolic blood pressure; FPG, fast plasma glucose; HbA1c, glycated hemoglobin; HDL, high-density lipoprotein; LDL, low-density lipoprotein; PP, pulse pressure; SBP, systolic blood pressure; TC, total cholesterol.